Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lidocaine hydrochloride + glycerin + benzalkonium chloride is a multi-component pharmaceutical formulation used for topical anesthesia, lubrication, and antiseptic protection. Lidocaine hydrochloride is an amide-type local anesthetic that stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, which prevents the initiation and conduction of nerve impulses. Benzalkonium chloride, a quaternary ammonium compound, serves as a rapidly acting surface antiseptic that disrupts microbial cell membranes, providing broad-spectrum antimicrobial activity against bacteria and fungi. Glycerin (glycerol) acts as a humectant and lubricant in urological applications, facilitating the insertion of catheters or endoscopic instruments. In otic preparations, glycerin provides osmotic activity to reduce edema in the ear canal. This combination is primarily indicated for urethral anesthesia during medical procedures and for the symptomatic relief of ear pain associated with otitis media or externa.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine hydrochloride + glycerin + benzalkonium chloride.